Prevention of epilepsy by taurine treatments in mice experimental model

Journal of Neuroscience Research

Volumn 87, Issue 6, 2009, Pages 1500-1508

  Junyent, F ^a   Utrera, J ^a   Romero, R ^a   Pallas M ^a   Camins, A ^a   Duque, D ^a   Auladell, Carme ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Kainic acid; Neurodegeneration; Neuroprotection

Indexed keywords

KAINIC ACID; TAURINE; ANTICONVULSIVE AGENT; CALPAIN; NEUROPROTECTIVE AGENT; PROTEIN C FOS;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; EPILEPSY; EXTRACELLULAR MATRIX; MALE; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; BRAIN; CELL DEATH; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; GLIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; SEIZURE;

ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; BRAIN; CALPAIN; CELL DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; EPILEPSY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MALE; MICE; NEUROGLIA; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-FOS; SEIZURES; TAURINE;

EID: 65549095445     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21950     Document Type: Article

References (71)

1. Araujo IM, Gil JM, Carreira BP, Mohapel P, Petersen A, Pinheiro PS, Soulet D, Bahr BA, Brundin P, Carvalho CM. 2008. Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. J Neurochem (in press).
2. Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, van Rijen PC, Troost D, da Silva FH, Wadman WJ, Gorter JA. 2007. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26:497-511.
3. Baran H. 2006. Alterations of taurine in the brain of chronic kainic acid epilepsy model. Amino Acids 31:303-307.
4. Barbeau A, Donaldson J. 1974. Zinc, taurine, and epilepsy. Arch Neurol 30:52-58.
5. Ben-Ari Y, Cossart R. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 23:580-587.
6. Bi X, Chang V, Siman R, Tocco G, Baudry M. 1996. Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain. Brain Res 726:98-108.
7. Birdsall TC. 1998. Therapeutic applications of taurine. Altern Med Rev 3:128-136.
8. Blumcke I, Becker AJ, Klein C, Scheiwe C, Lie AA, Beck H, Waha A, Friedl MG, Kuhn R, Emson P, Elger C, Wiestler OD. 2000. Temporal lobe epilepsy associated up-regulation of metabotropic glutamate receptors: correlated changes in mGluR1 mRNA and protein expression in experimental animals and human patients. J Neuropathol Exp Neurol 59:1-10.
9. Cavalheiro EA, Riche DA, Le Gal La Salle G. 1982. Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures. Electroencephalogr Clin Neurophysiol 53:581-589.
10. Cavazos JE, Jones SM, Cross DJ. 2004. Sprouting and synaptic reorganization in the subiculum and CA1 region of the hippocampus in acute and chronic models of partial-onset epilepsy. Neuroscience 126:677-688.
11. Della Corte L, Crichton RR, Duburs G, Nolan K, Tipton KF, Tirzitis G, Ward RJ. 2002. The use of taurine analogues to investigate taurine functions and their potential therapeutic applications. Amino Acids 23:367-379.
12. Dopico JG, Gonzalez-Hernandez T, Perez IM, Garcia IG, Abril AM, Inchausti JO, Rodriguez Diaz M. 2006. Glycine release in the substantia nigra: interaction with glutamate and GABA. Neuropharmacology 50:548-557.
13. Dragunow M, Goulding M, Faull RL, Ralph R, Mee E, Frith R. 1990. Induction of c-fos mRNA and protein in neurons and glia after traumatic brain injury: pharmacological characterization. Exp Neurol 107:236-248.
14. Dudek FE. 2002. Role of glial cells in seizures and epilepsy: intracellular calcium oscillations sn spatial buffering. Epilepsy Curr 2:137-139.
15. Dudek FE, Hellier JL, Williams PA, Ferraro DJ, Staley KJ. 2002. The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus. Prog Brain Res 135:53-65.
16. El Idrissi A, Trenkner E. 1999. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459-9468.
17. El Idrissi A, Trenkner E. 2003. Taurine regulates mitochondrial calcium homeostasis. Adv Exp Med Biol 526:527-536.
18. Engel J Jr, Babb TL, Crandall PH. 1989. Surgical treatment of epilepsy: opportunities for research into basic mechanisms of human brain function. Acta Neurochir Suppl 46:3-8.
19. French ED, Vezzani A, Whetsell WO Jr, Schwarcz R. 1986. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol 203:349-362.
20. Gupta RC, Win T, Bittner S. 2005. Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr Med Chem 12:2021-2039.
21. Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE. 1998. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31:73-84.
22. Hendil KB, Hoffmann EK. 1974. Cell volume regulation in Ehrlich ascites tumor cells. J Cell Physiol 84:115-125.
23. Huxtable RJ. 1989. Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32:471-533.
24. Huxtable RJ. 1992. Physiological actions of taurine. Physiol Rev 72:101-163.
25. Izumi K, Butterworth RF, Barbeau A. 1977. Effect of taurine on calcium binding to microsomes isolated from rat cerebral cortex. Life Sci 20:943-950.
26. Jacobson I, Hamberger A. 1985. Kainic acid-induced changes of extracellular amino acid levels, evoked potentials and EEG activity in the rabbit olfactory bulb. Brain Res 348:289-296.
27. Kondratyev A, Gale K. 2004. Latency to onset of status epilepticus determines molecular mechanisms of seizure-induced cell death. Brain Res Mol Brain Res 121:86-94.
28. Kreutzberg GW. 1995. Microglia, the first line of defence in brain pathologies. Arzneimittelforschung 45:357-360.
29. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
30. Lallemand F, De Witte P. 2004. Taurine concentration in the brain and in the plasma following intraperitoneal injections. Amino Acids 26:111-116.
31. Law RO. 1998. The role of taurine in the regulation of brain cell volume in chronically hyponatraemic rats. Neurochem Int 33:467-472.
32. Lee MY, Kim SY, Choi JS, Choi YS, Jeon MH, Lee JH, Kim IK. 2002. Induction of Bis, a Bcl-2-binding protein, in reactive astrocytes of the rat hippocampus following kainic acid-induced seizure. Exp Mol Med 34:167-171.
33. Lehmann A, Isacsson H, Hamberger A. 1983. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J Neurochem 40:1314-1320.
34. Lehmann A, Hagberg H, Jacobson I, Hamberger A. 1985. Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res 359:147-151.
35. Leite JP, Garcia-Cairasco N, Cavalheiro EA. 2002. New insights from the use of pilocarpine and kainate models. Epilepsy Res 50:93-103.
36. Lerma J, Herranz AS, Herreras O, Abraira V, Martin del Rio R. 1986. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res 384:145-155.
37. Magnusson KR, Koerner JF, Larson AA, Smullin DH, Skilling SR, Beitz AJ. 1991. NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Res 549:1-8.
38. Miles R, Wong RK. 1983. Single neurones can initiate synchronized population discharge in the hippocampus. Nature 306:371-373.
39. Morgan JI, Cohen DR, Hempstead JL, Curran T. 1987. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 237:192-197.
40. Mulle C, Sailer A, Perez-Otano I, Dickinson-Anson H, Castillo PE, Bureau I, Maron C, Gage FH, Mann JR, Bettler B, Heinemann SF. 1998. Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392:601-605.
41. Muramatsu M, Kakita K, Nakagawa K, Kuriyama K. 1978. A modulating role of taurine on release of acetylcholine and norepinephrine from neuronal tissues. Jpn J Pharmacol 28:259-268.
42. Mutani R, Durelli L, Mazzarino M, Valentini C, Monaco F, Fumero S, Mondino A. 1977. Longitudinal changes of brain amino acid content occurring before, during and after epileptic activity. Brain Res 122:513-521.
43. Nagelhus EA, Lehmann A, Ottersen OP. 1993. Neuronal-glial exchange of taurine during hypo-osmotic stress: a combined immunocytochemical and biochemical analysis in rat cerebellar cortex.Neuroscience 54:615-631.
44. Niquet J, Ben-Ari Y, Represa A. 1994. Glial reaction after seizure induced hippocampal lesion: immunohistochemical characterization of proliferating glial cells. J Neurocytol 23:641-656.
45. Olney JW, Rhee V, Ho OL. 1974. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77:507-512.
46. Olney JW, Fuller T, de Gubareff T. 1979. Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res 176:91-100.
47. Palkovits M, Elekes I, Lang T, Patthy A. 1986. Taurine levels in discrete brain nuclei of rats. J Neurochem 47:1333-1335.
48. 2+ sequestration by taurine. Biochem Pharmacol 58:1123-1131.
49. Pasantes-Morales H, Dominguez L, Campomanes MA, Pacheco P. 1986. Retinal degeneration induced by taurine deficiency in light-deprived cats. Exp Eye Res 43:55-60.
50. Pasantes-Morales H, Franco R, Torres-Marquez ME, Hernandez-Fonseca K, Ortega A. 2000. Amino acid osmolytes in regulatory volume decrease and isovolumetric regulation in brain cells: contribution and mechanisms. Cell Physiol Biochem 10:361-370.
51. Pazdernik TL, Wade JV, Nelson SR, Samson FE. 1990. Is taurine involved in cerebral osmoregulation? Prog Clin Biol Res 351:377-384.
52. Pitkanen A, Nissinen J, Nairismagi J, Lukasiuk K, Grohn OH, Miettinen R, Kauppinen R. 2002. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 135:67-83.
53. Popovici T, Represa A, Crepel V, Barbin G, Beaudoin M, Ben-Ari Y. 1990. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res 536:183-194.
54. Rao MS, Hattiangady B, Reddy DS, Shetty AK. 2006. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J Neurosci Res 83:1088-1105.
55. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. 2008. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142-160.
56. Represa A, Niquet J, Pollard H, Ben-Ari Y. 1995. Cell death, gliosis, and synaptic remodeling in the hippocampus of epileptic rats. J Neurobiol 26:413-425.
57. Riban V, Bouilleret V, Pham-Le BT, Fritschy JM, Marescaux C, Depaulis A. 2002. Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112:101-111.
58. Schmued LC, Albertson C, Slikker W Jr. 1997. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751:37-46.
59. Schmued LC, Hopkins KJ. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
60. Schreiber SS, Najm I, Tocco G, Baudry M. 1993. Co-expression of HSP72 and c-fos in rat brain following kainic acid treatment. Neuroreport 5:269-272.
61. Schurr A, Tseng MT, West CA, Rigor BM. 1987. Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci 40:2059-2066.
62. Setkowicz Z, Guzik R. 2007. Injections of vehicle, but not cyclosporin A or tacrolimus (FK506), afford neuroprotection following injury in the developing rat brain. Acta Neurobiol Exp 67:399-409.
63. Solis JM, Herranz AS, Herreras O, Lerma J, Martin del Rio R. 1988. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci Lett 91:53-58.
64. Trenkner E. 1990. The role of taurine and glutamate during early postnatal cerebellar development of normal and weaver mutant mice. Adv Exp Med Biol 268:239-244.
65. Van Gelder NM, Sherwin AL, Rasmussen T. 1972. Amino acid content of epileptogenic human brain: focal versus surrounding regions. Brain Res 40:385-393.
66. Wade JV, Samson FE, Nelson SR, Pazdernik TL. 1987. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J Neurochem 49:645-650.
67. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdernik TL. 1988. A possible role for taurine in osmoregulation within the brain. J Neurochem 51:740-745.
68. Wilson CL, Maidment NT, Shomer MH, Behnke EJ, Ackerson L, Fried I, Engel J Jr. 1996. Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res 26:245-254.
69. Wright CE, Tallan HH, Lin YY, Gaull GE. 1986. Taurine: biological update. Annu Rev Biochem 55:427-453.
70. Wu H, Jin Y, Wei J, Jin H, Sha D, Wu JY. 2005. Mode of action of taurine as a neuroprotector. Brain Res 1038:123-131.
71. Wu JY, Lin CT, Johansen FF, Liu JW. 1994. Taurine neurons in rat hippocampal formation are relatively inert to cerebral ischemia. Adv Exp Med Biol 359:289-298.